No photo of Martijn van Oijen

Martijn van Oijen

20192019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article
2019

Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy

Dijksterhuis, W. P. M., Pruijt, M. J., van der Woude, S. O., Klaassen, R., Kurk, S. A., van Oijen, M. G. H. & van Laarhoven, H. W. M., 1 Feb 2019, In : Journal of Cachexia, Sarcopenia and Muscle. 10, 1, p. 199-206

Research output: Contribution to journalArticleAcademicpeer-review

Open Access
Open Access

Cutaneous Toxicity After Chemoradiotherapy and PD-L1 Inhibition in Two Patients with Esophageal Adenocarcinoma: More than Meets the Eye

van den Ende, T., Menting, S. P., Ambarus, C. A., van Oijen, M. G. H. & van Laarhoven, H. W. M., 1 Apr 2019, In : Oncologist. 24, 4, p. e149-e153

Research output: Contribution to journalArticleAcademicpeer-review

Heterogeneity of first-line palliative systemic treatment in synchronous metastatic esophagogastric cancer patients: A real-world evidence study

Dijksterhuis, W. P. M., Verhoeven, R. H. A., Slingerland, M., Haj Mohammad, N., de Vos-Geelen, J., Beerepoot, L. V., van Voorthuizen, T., Creemers, G-J., van Oijen, M. G. H. & van Laarhoven, H. W. M., 1 Jan 2019, In : International Journal of Cancer.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Phase I Dose escalation study with expansion cohort of the addition of nab-paclitaxel to capecitabine and oxaliplatin (CapOx) as first-line treatment of metastatic esophagogastric adenocarcinoma (ACTION study)

Schokker, S., van der Woude, S. O., van Kleef, J. J., van Zoen, D. J., van Oijen, M. G. H., Mearadji, B., Beenen, L. F. M., Stroes, C. I., Waasdorp, C., Jibodh, R. A., Creemers, A., Meijer, S. L., Hooijer, G. K. J., Punt, C. J. A., Bijlsma, M. F. & van Laarhoven, H. W. M., 1 Jun 2019, In : Cancers. 11, 6, 827.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

SOURCE: A registry-based prediction model for overall survival in patients with metastatic oesophageal or gastric cancer

van den Boorn, H. C. G., Abu-Hanna, A., ter Veer, E., van Kleef, J. J., Lordick, F., Stahl, M., Ajani, J. A., Guimbaud, R., Park, S. H., Dutton, S. J., Bang, Y-J., Boku, N., Mohammad, N. H., Sprangers, M. A. G., Verhoeven, R. H. A., Zwinderman, A. H., van Oijen, M. G. H. & van Laarhoven, H. W. M., 1 Feb 2019, In : Cancers. 11, 2, 187.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

The efficacy and safety of (Neo)adjuvant therapy for gastric cancer: A network meta-analysis

van den Ende, T., ter Veer, E., Machiels, M. L., Mali, R. M. A., Abe Nijenhuis, F. A., de Waal, L., Laarman, M., Gisbertz, S. S., Hulshof, M. C. C. M., van Oijen, M. G. H. & van Laarhoven, H. W. M., 1 Jan 2019, In : Cancers. 11, 1, 80.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

The use of (Network) meta-analysis in clinical oncology

ter Veer, E., van Oijen, M. G. H. & van Laarhoven, H. W. M., 1 Jan 2019, In : Frontiers in Oncology. 9, AUG, 822.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access